Table 2: The major outcomes of EAL-10 and EAL-14 eradication therapy.

Eradication rate
EAL-10 ( )EAL-14 ( ) value

Intention-to-treat68% (68/100)86% (86/100)0.002
Per-protocol75.6% (68/90)92.5% (86/93)0.002
Adverse event11% (11/100)16% (16/100)0.301
Compliance100% (100/100)99% (99/100)1.000

EAL-10: esomeprazole/amoxicillin/levofloxacin triple therapy 10 days and EAL-14: esomeprazole/amoxicillin/levofloxacin triple therapy 14 days.